Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$5.25 and last traded at C$4.91, with a volume of 44910 shares traded. The stock had previously closed at C$5.07.
Medexus Pharmaceuticals Stock Down 3.0%
The firm has a market cap of C$155.77 million, a P/E ratio of -70.29 and a beta of 0.22. The firm’s 50-day moving average price is C$4.12 and its 200 day moving average price is C$3.45.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Stories
- Five stocks we like better than Medexus Pharmaceuticals
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
